HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution

Sdílet
Vložit
  • čas přidán 9. 07. 2024
  • Presented By: Yann Christinat, PhD & Stephan Bartels, PhD
    Webinar: HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution
    Webinar Abstract: Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, induce synthetic lethality in tumors with high levels of HRD...
    Labroots on Social:
    Facebook: / labrootsinc
    Twitter: / labroots
    LinkedIn: / labroots
    Instagram: / labrootsinc
    Pinterest: / labroots
    SnapChat: labroots_inc
  • Věda a technologie

Komentáře •